ReviewWorld journal of gastroenterology2021
Endoscopic anti-reflux therapy for gastroesophageal reflux disease.
Review in World journal of gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05899491 (Role of ARMA in Selective Subset of Refractory GERD Patients- A Randomized Sham Control Trial.), which is not on this map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Role of ARMA in Selective Subset of Refractory GERD Patients- A Randomized Sham Control Trial.
Who cites it
17 citing papers in PubMed.
- Efficacy and Safety of Closure-Focused Anti-Reflux Mucoplasty Compared With Conventional ARMS: A Propensity Score-Matched Study (With Video).Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2026Article
- A pilot study on anti-reflux mucoplasty with valve as novel endoscopic therapy for gastroesophageal reflux disease.DEN open · 2026Article
- Efficacy and safety of endoscopic cardia constriction ligation with a single-use endoscope versus a reusable endoscope for refractory gastroesophageal reflux disease: protocol for a multicenter randomized controlled trial.Frontiers in medicine · 2026Article
- Reflux Esophagitis.The Korean journal of helicobacter and upper gastrointestinal research · 2025Review
- Development and Application of Endoscopic Antireflux Mucosectomy in Treating Refractory Gastroesophageal Reflux Disease.Gastroenterology research and practice · 2025Review
- Improving treatment of people with gastro-esophageal reflux disease refractory to proton pump inhibitors.Communications medicine · 2024Review
- Problems with repairing gut sphincters malfunctions.World journal of gastrointestinal surgery · 2024Article
- Pilot study on anti-reflux mucoplasty: Advancing endoscopic anti-reflux therapy for gastroesophageal reflux disease.Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2024Article
- Endoscopic Non-ablative Radiofrequency Treatment (Stretta) for Gastroesophageal Reflux Disease (GERD).Current gastroenterology reports · 2024Review
- A Newly Reported Late Complication of Endoscopic Fundoplication: A Case Report.Reports (MDPI) · 2024Article
- The Potential of Collagen Treatment for Comorbid Diseases.Polymers · 2023Review
- Does hiatal hernia impact gastro-oesophageal reflux-related chronic cough?ERJ open research · 2023Article
- To the Editor: Reply to He J., Yin Y., Tang W., et al. Objective Outcomes of an Extended Anti-Reflux Mucosectomy in the Treatment of PPI-Dependent Gastroesophageal Reflux Disease (with Video). J Gastrointest Surg. 2022.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2023Article
- Current management of gastro-oesophageal reflux disease-treatment costs, safety profile, and effectiveness: a narrative review.Gastroenterology report · 2023Review
- Is patient satisfaction sufficient to validate endoscopic anti-reflux treatments?World journal of gastroenterology · 2022Article
- Clinical efficacy of endoscopic antireflux mucosectomyAnnals of translational medicine · 2022Article
- [Endoscopic Anti-Reflux Therapy for Gastroesophageal Reflux Disease: A Present-Day Perspective].Acta gastroenterologica LatinoamericanaReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastroesophageal reflux disease has an increasing incidence and prevalence worldwide. A significant proportion of patients have a suboptimal response to proton pump inhibitors or are unwilling to take lifelong medication due to concerns about long-term adverse effects. Endoscopic anti-reflux therapies offer a minimally invasive option for patients unwilling to undergo surgical treatment or take lifelong medication. The best candidates are those with a good response to proton pump inhibitors and without a significant sliding hiatal hernia. Transoral incisionless fundoplication and nonablative radiofrequency are the techniques with the largest body of evidence and that have been tested in several randomized clinical trials. Band-assisted ligation techniques, anti-reflux mucosectomy, anti-reflux mucosal ablation, and new plication devices have yielded promising results in recent noncontrolled studies. Nonetheless, the role of endoscopic procedures remains controversial due to limited long-term and comparative data, and no consensus exists in current clinical guidelines. This review provides an updated summary focused on the patient selection, technical details, clinical success, and safety of current and future endoscopic anti-reflux techniques.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.